Literature DB >> 15697240

DNAzyme-mediated silencing of ornithine decarboxylase.

Joseph M Ackermann1, Sreenivas Kanugula, Anthony E Pegg.   

Abstract

The value of reducing the activity of ornithine decarboxylase (ODC), a key enzyme in the biosynthesis of polyamines, is well-appreciated. Polyamines are necessary components for cell growth, and manipulation of polyamine homeostasis may be an effective strategy for the treatment of a number of disorders, including neoplastic diseases. An approach to develop an effective DNAzyme, using the 10-23 model, against ODC is described in these studies. DNAzymes able to cleave the target ODC RNA were identified in vitro and further characterized by the effect each had on ODC protein and activity levels using in vitro translated ODC RNA. ODC protein levels and activity correlated well with the RNA cleavage activity of the DNAzyme. One of the DNAzymes, DZ IV, which exhibited good activity, was optimized for use in cell culture studies. The DNAzyme hybridization arms were altered from equal length arms varying in length (8, 9, 10, or 11 nucleotides) or to unequal length arms (7/11 nucleotides), and kinetic analyses were performed to identify the most catalytically efficient configuration. DZ IV with equal arms nine nucleotides in length proved to be the most catalytically efficient. In HEK 293 cells, DZ IV was able to reduce the amount of translated ODC protein, resulting in approximately 80% reduction in ODC activity-a statistically significant enhancement over the apparent antisense effect of a catalytically inactive DNAzyme. These results indicate that this DNAzyme may be a useful tool to study the function of ODC and may have potential therapeutic uses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15697240     DOI: 10.1021/bi047918d

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  4 in total

Review 1.  In vitro selection, characterization, and application of deoxyribozymes that cleave RNA.

Authors:  Scott K Silverman
Journal:  Nucleic Acids Res       Date:  2005-11-11       Impact factor: 16.971

2.  Locked nucleoside analogues expand the potential of DNAzymes to cleave structured RNA targets.

Authors:  Birte Vester; Lykke H Hansen; Lars Bo Lundberg; B Ravindra Babu; Mads D Sørensen; Jesper Wengel; Stephen Douthwaite
Journal:  BMC Mol Biol       Date:  2006-06-05       Impact factor: 2.946

3.  Novel Chemically-modified DNAzyme targeting Integrin alpha-4 RNA transcript as a potential molecule to reduce inflammation in multiple sclerosis.

Authors:  Madhuri Chakravarthy; May T Aung-Htut; Bao T Le; Rakesh N Veedu
Journal:  Sci Rep       Date:  2017-05-09       Impact factor: 4.379

4.  Development of Novel Chemically-Modified Nucleic Acid Molecules for Efficient Inhibition of Human MAPT Gene Expression.

Authors:  Madhuri Chakravarthy; Suxiang Chen; Tao Wang; Rakesh N Veedu
Journal:  Genes (Basel)       Date:  2020-06-19       Impact factor: 4.096

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.